(Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by ...
Strong Product Demand: We are upbeat about DexCom's continued strength in CGM products. DexCom demonstrated strong product demand in third-quarter 2024, highlighted by record new patient starts in ...
Oversold Healthcare Stocks to Buy The sale of CGM devices is the primary revenue generator for the company, along with software and other services. Its top products include the Dexcom G6 which ...